Search research articles
Contact Us
Filters
Showing results (61-70 of 88) with videos related to
Page
of 9
Sort By:
Leukemia
|
January 26, 2007
Phosphoproteomic analysis identifies the M0-91 cell line as a cellular model for the study of TEL-TRKC fusion-associated leukemia
T-L Gu, L Popova, C Reeves, et al.
Oncogene
|
June 1, 1989
Activation of the GM-CSF promoter by HTLV-I and -II tax proteins
S D Nimer, J C Gasson, K Hu, et al.
Oncogene
|
January 11, 2007
Tumor promoting properties of the ETS protein MEF in ovarian cancer
J J Yao, Y Liu, H D Lacorazza, et al.
Bone Marrow Transplantation
|
January 12, 2010
Retrospective comparison of the effects of filgrastim and pegfilgrastim on the pace of engraftment in auto-SCT patients
S Mathew, N Adel, R D Rice, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1989
Efficacy of intensive chemotherapy for acute myelogenous leukemia associated with a preleukemic syndrome
J L Gajewski, W G Ho, S D Nimer, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 18, 2001
Macrophage-derived chemokine expression in classical Hodgkin's lymphoma: application of tissue microarrays
C V Hedvat, E S Jaffe, J Qin, et al.
Gene Expression
|
January 1, 1995
Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping
M E Greene, B Blumberg, O W McBride, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Factors affecting mobilization of peripheral blood progenitor cells in patients with lymphoma
C H Moskowitz, J R Glassman, D Wuest, et al.
Transplantation
|
January 1, 1994
Selective depletion of CD8+ cells for prevention of graft-versus-host disease after bone marrow transplantation. A randomized controlled trial
S D Nimer, J Giorgi, J L Gajewski, et al.
Leukemia
|
December 2, 2005
Results of a phase I/II trial adding carmustine (300 mg/m2) to melphalan (200 mg/m2) in multiple myeloma patients undergoing autologous stem cell transplantation
R L Comenzo, H Hassoun, T Kewalramani, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 88) with videos related to
Sort By:
Page
of 9
Leukemia
|
January 26, 2007
Phosphoproteomic analysis identifies the M0-91 cell line as a cellular model for the study of TEL-TRKC fusion-associated leukemia
T-L Gu, L Popova, C Reeves, et al.
Oncogene
|
June 1, 1989
Activation of the GM-CSF promoter by HTLV-I and -II tax proteins
S D Nimer, J C Gasson, K Hu, et al.
Oncogene
|
January 11, 2007
Tumor promoting properties of the ETS protein MEF in ovarian cancer
J J Yao, Y Liu, H D Lacorazza, et al.
Bone Marrow Transplantation
|
January 12, 2010
Retrospective comparison of the effects of filgrastim and pegfilgrastim on the pace of engraftment in auto-SCT patients
S Mathew, N Adel, R D Rice, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1989
Efficacy of intensive chemotherapy for acute myelogenous leukemia associated with a preleukemic syndrome
J L Gajewski, W G Ho, S D Nimer, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 18, 2001
Macrophage-derived chemokine expression in classical Hodgkin's lymphoma: application of tissue microarrays
C V Hedvat, E S Jaffe, J Qin, et al.
Gene Expression
|
January 1, 1995
Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping
M E Greene, B Blumberg, O W McBride, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Factors affecting mobilization of peripheral blood progenitor cells in patients with lymphoma
C H Moskowitz, J R Glassman, D Wuest, et al.
Transplantation
|
January 1, 1994
Selective depletion of CD8+ cells for prevention of graft-versus-host disease after bone marrow transplantation. A randomized controlled trial
S D Nimer, J Giorgi, J L Gajewski, et al.
Leukemia
|
December 2, 2005
Results of a phase I/II trial adding carmustine (300 mg/m2) to melphalan (200 mg/m2) in multiple myeloma patients undergoing autologous stem cell transplantation
R L Comenzo, H Hassoun, T Kewalramani, et al.
Page
of 9